191.038 articles found

The effects of acupuncture and electroacupuncture on Parkinson's disease: Current status and future perspectives for molecular mechanisms.

Tamtaji OR, Naderi Taheri M, Notghi F, Alipoor R, Bouzari R, Asemi Z.

J Cell Biochem · 2019-04-02

DOI: 10.1002/jcb.28654PMID: 30938859

Predictors of Penetration-Aspiration in Parkinson's Disease Patients With Dysphagia: A Retrospective Analysis.

Gaeckle M, Domahs F, Kartmann A, Tomandl B, Frank U.

Ann Otol Rhinol Laryngol · 2019-04-02

DOI: 10.1177/0003489419841398PMID: 30939890

The effect of ultrasonic irradiation on the morphology of NiO/Co₃O₄ nanocomposite and its application to the simultaneous electrochemical determination of droxidopa and carbidopa.

Torkzadeh-Mahani R, Foroughi MM, Jahani S, Kazemipour M, Hassani Nadiki H.

Ultrason Sonochem · 2019-04-02

DOI: 10.1016/j.ultsonch.2019.04.002PMID: 31101254

Ultrasound-assisted synthesis of α-MnS (alabandite) nanoparticles decorated reduced graphene oxide hybrids: Enhanced electrocatalyst for electrochemical detection of Parkinson's disease biomarker.

Chen TW, Rajaji U, Chen SM, Li YL, Ramalingam RJ.

Ultrason Sonochem · 2019-04-02

DOI: 10.1016/j.ultsonch.2019.04.010PMID: 31101276

Genetic Association Between NGFR, ADAM17 Gene Polymorphism, and Parkinson's Disease in the Chinese Han Population.

Li WW, Shen YY, Chen DW, Li HY, Shi QQ, Mei J, Yang H, Zhou FY, Shi AY, Zhang T, Yao XQ, Xu ZQ, Zeng F, Wang YJ.

Neurotox Res · 2019-04-02

DOI: 10.1007/s12640-019-00031-zPMID: 30941646

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

van Eimeren T, Antonini A, Berg D, Bohnen N, Ceravolo R, Drzezga A, Höglinger GU, Higuchi M, Lehericy S, Lewis S, Monchi O, Nestor P, Ondrus M, Pavese N, Peralta MC, Piccini P, Pineda-Pardo JÁ, Rektorová I, Rodríguez-Oroz M, Rominger A, Seppi K, Stoessl AJ, Tessitore A, Thobois S, Kaasinen V, Wenning G, Siebner HR, Strafella AP, Rowe JB.

Alzheimers Dement (Amst) · 2019-04-02

DOI: 10.1016/j.dadm.2019.01.011PMID: 30984816

Understanding ligands driven mechanism of wild and mutant aryl hydrocarbon receptor in presence of phytochemicals combating Parkinson's disease: an <i>in silico</i> and <i>in vivo</i> study.

Rath SN, Jena L, Patri M.

J Biomol Struct Dyn · 2019-04-02

DOI: 10.1080/07391102.2019.1590240PMID: 30836878

Is there a halo-enzymopathy in Parkinson's disease?

Fernández-Espejo E.

Neurologia (Engl Ed) · 2019-04-02

DOI: 10.1016/j.nrl.2018.12.008PMID: 30952477

F28. CLINICAL VALIDATION OF THE GLASGOW ANTIPSYCHOTIC SIDE EFFECT SCALE (GASS)

Bock M, van Achter O, Dines D, Correll C, Mors O, Østergaard S, Kølbæk P.

Schizophrenia bulletin · 2019-04-01

T21. ASSOCIATIONS BETWEEN MOTOR ABNORMALITIES AND PSYCHOTIC SYMPTOMS IN NON-HELP-SEEKING INDIVIDUALS AT RISK FOR PSYCHOSIS

Wang S, Lam B, Hsu H, Cheung V.

Schizophrenia bulletin · 2019-04-01

S114. EFFICACY OF THE SEROTONIN 5HT-2A INVERSE AGONIST PIMAVANSERIN IN REFRACTORY HALLUCINATIONS AND DELUSIONS THAT FAILED TO RESPOND TO CLOZAPINE OR OTHER ANTIPSYCHOTICS

Nasrallah H, Fedora R, Morton R.

Schizophrenia bulletin · 2019-04-01

S72. FUNCTIONAL DISCONNECTION WITHIN THE PRESENCE HALLUCINATION NETWORK IN PSYCHOTIC PATIENTS WITH FIRST-RANK SYMPTOMS

Stripeikyte G, Rognini G, Faivre N, Potheegadoo J, Progin P, Hagmann P, Conus P, Do K, Blanke O.

Schizophrenia bulletin · 2019-04-01